
David Silverstein, JD, MS, a partner in Axinn’s Intellectual Property Practice Group and FDA practice groups, discusses the implications of the White House support for the proposal presented to the WTO to waive IP protections for COVID-19 vaccines.

David Silverstein, JD, MS, a partner in Axinn’s Intellectual Property Practice Group and FDA practice groups, discusses the implications of the White House support for the proposal presented to the WTO to waive IP protections for COVID-19 vaccines.

The COVID-19 pandemic has had a massive impact on pharmacy students’ educations, according to a group of third-year students from the Washington State University College of Pharmacy and Pharmaceutical Sciences.

Addressing the underlying causes of pharmacist burnout is essential, according to Melissa Santibañez, PharmD, BCCCP, a critical care clinical pharmacist at Memorial Regional Hospital.

Students at the Washington State University (WSU) College of Pharmacy and Pharmaceutical Sciences discussed opportunities at WSU that have been important stepping stones for their careers.

Mathew Reynolds, PhD, IQIVA, vice president of real-world evidence at IQVIA, discussed how the COVID-19 pandemic has affected regular health screenings, mail-order dispensing, and home infusions.

Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss the value of the pharmacist in the health and wellness space for patients.

Pharmacy Times spoke with Lauren Simko, managing performance specialist at Pharmacy Development Services, about the future of lengthening the patient lifecycle and further developing pharmacy services.

Pharmacy Times spoke with Lauren Simko, managing performance specialist at Pharmacy Development Services, about how an improved patient experience goes hand-in-hand with lifecycle.

Pharmacy Times spoke with Lauren Simko, managing performance specialist at Pharmacy Development Services, about how elevating the patient experience can increase revenue for pharmacists in the healthcare space.

Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss the role of social media in the health and wellness space.

Ssatuximab (Sarclisa, Sanofi) is used in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma.

Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss whether the shift in the public's awareness of the critical role of the pharmacist during the pandemic could support pharmacists’ move to a more significant role in the health and wellness space.

Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss challenges pharmacists may face while expanding into the health and wellness space.

Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss the 2021 Virtual PDS Conference session on growth opportunities in the health and wellness space for pharmacy.

Simko discussed how to retain new patients to continue to bring in new opportunities and better results for pharmacies everywhere.

Pharmacy Times spoke with Lauren Simko, managing performance specialist at Pharmacy Development Services, about her presentation "Elevated Patients Experiences: Lengthen the Patient Lifecycle to Increase Revenue."

Hannah Fish, PharmD, associate director of strategic initiatives at NCPA, discusses the role of the pharmacist in vaccinating children ages 12 and older against COVID-19 following the FDA updating the Pfizer COVID-19 vaccine EUA.

See how convenient self-infusions can be with Hizentra prefilled syringes. Watch the video.

No more vial transfers! First and only Hizentra prefilled syringes are simple, convenient, and ready to use. Elimination of vial transfer may reduce steps and effort, depending on dose. Watch the short video to learn more.

Melphalan flufenamide (Pepaxto; melflufen) is approved for use in combination with dexamethasone to treat adult patients with relapsed or refractory multiple myeloma.

Recent surveys have found high rates of occupational burnout among hematology and oncology pharmacists, with more than half or survey respondents reporting burnout.

Matthew Harms, a medical consultant and care center director at the MDA and associate professor of neurology at Columbia University Medical Center, to discuss new treatments and anticipated developments for ALS over the next year.

Pharmacy Times® spoke with Tomas Villanueva, DO, MBA, FACPE, SFHM, practicing health care provider, and associate vice president for clinical resources at Vizient, about vaccine hesitancy among health care workers.

In a recent Student Café series, we asked students at the Washington State University (WSU) College of Pharmacy and Pharmaceutical Sciences what drew them to study at WSU.

As accessible health care providers with links to all facets of the health care system, pharmacists are perfectly positioned to organize COVID-19 vaccine distribution in their communities.

Hannah Fish, PharmD, National Community Pharmacists Association associate director of Strategic Initiatives, discusses the next phase of the COVID-19 vaccination rollout following the FDA expanding the Pfizer-BioNTech COVID-19 vaccine EUA to include children ages 12 and older.

Erenumab-aooe (Aimovig, Amgen) is indicated for the preventive treatment of migraine in adults, making it the first approved preventive migraine treatment of its kind.

Working with colleagues or patients from different cultural backgrounds requires an open mind, especially when addressing common issues such as vaccine hesitancy.

Vericiguat (Verquvo, Merck) is indicated to reduce the risk of cardiovascular death, heart failure hospitalizations, or the need for outpatient intravenous diuretics.
Pharmacy Times® interviewed the CEO of US Pharmacopeia (USP) Ronald Piervincenzi, PhD, to discuss USP’s history, the role of the pharmacist both in that history and in USP’s work today, and USP’s outlook on the future of pharmacy.